Clinical Trials Directory

Trials / Unknown

UnknownNCT04507711

Palonosetron and Blood Coagulation

The Effect of a Palonosetron on Blood Coagulation: In Vitro, Volunteer Study Using Thromboelastography

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

Palonosetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of palonosetron. The investigators therefore will perform the present study to measure the effect of palonosetron levels using thromboelastography.

Conditions

Interventions

TypeNameDescription
DRUG0 ul of palonosetronVenous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (0 ul) using palonosetron
DRUG1 ul of palonosetronVenous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (1 ul) using palonosetron
DRUG10 ul of palonosetronVenous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (10 ul) using palonosetron
DRUG100 ul of palonosetronVenous blood is taken from 11 healthy volunteers and divided into four specimen bottles, which were added with different doses (100 ul) using palonosetron

Timeline

Start date
2020-09-16
Primary completion
2023-11-15
Completion
2023-12-15
First posted
2020-08-11
Last updated
2023-03-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04507711. Inclusion in this directory is not an endorsement.

Palonosetron and Blood Coagulation (NCT04507711) · Clinical Trials Directory